MoneyWorks4Me

The company witnessed a 10.35% growth in the revenue at Rs. 388.42 millions for the quarter ended March 2024 as compared to Rs. 351.99 millions during the year-ago period.The Company has registered profit of Rs. 78.83  millions for the quarter ended March 2024, a growth of 24.06%  over Rs. 63.54 millions millions achieved in the corresponding quarter of last year.Operating profit for the quarter ended March 2024 rose to 110.42 millions as compared to 87.54 millions of corresponding quarter ended March 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 388.42 351.99 10.35 1419.66 1367.49 3.82 1419.66 1367.49 3.82
Other Income 11.89 12.56 -5.33 46.67 51.23 -8.90 46.67 51.23 -8.90
PBIDT 110.42 87.54 26.14 377.85 354.90 6.47 377.85 354.90 6.47
Interest 0.58 0.84 -30.95 2.71 3.67 -26.16 2.71 3.67 -26.16
PBDT 109.84 86.70 26.69 375.14 351.23 6.81 375.14 351.23 6.81
Depreciation 6.18 5.94 4.04 23.40 22.59 3.59 23.40 22.59 3.59
PBT 103.66 80.76 28.36 351.74 328.64 7.03 351.74 328.64 7.03
TAX 24.83 17.22 44.19 91.98 82.58 11.38 91.98 82.58 11.38
Deferred Tax -1.68 1.62 -203.70 -5.21 -2.25 131.56 -5.21 -2.25 131.56
PAT 78.83 63.54 24.06 259.76 246.06 5.57 259.76 246.06 5.57
Equity 44.13 44.13 0.00 44.13 44.13 0.00 44.13 44.13 0.00
PBIDTM(%) 28.43 24.87 14.31 26.62 25.95 2.55 26.62 25.95 2.55
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..